Introduction
The importance of polyunsaturated fatty acids of the omega-3 (ω-3) series (docosahexaenoic acid [22:6 ω3 , DHA] and eicosapentaenoic acid [20:5 ω3, EPA]) in the development of the fetal brain, as well as in the cognitive and visual acuity of the child, is widely recognized. These fatty acids are part of the composition of the cell membranes and the nervous system, especially DHA, which is preferentially transported by the placenta to the fetus and provides important components to the phospholipid membrane. 1, 2 The amount of fatty acids in human milk (HM) depends on maternal stocks, dietary intake and synthesis thereof in the mammary glands. 3 The concentration of DHA varies specifically, probably due to the woman's feeding habits, since its synthesis in the mammary gland is minimal. 1, 2, 4 During gestation and lactation, this synthesis is limited by the fetus. For this reason, numerous studies have been conducted to evaluate the effects of the supplementation of this fatty acid on the composition of HM . 4, 5 Other facts to be taken into consideration are that the concentration of DHA in HM decreases as lactation progresses, and that supplementation during lactation raises DHA concentrations in breast milk. 6 The study conducted by Bortolozo et al (2013) 2 aimed to evaluate the impact of omega-3 fatty acid supplementation between the third trimester of pregnancy and the third month after delivery, and its influence on the composition of HM. Although no statistical difference was found in the total lipid values between the studied groups, the milk of mothers supplemented with fish oil had higher concentrations of DHA and EPA, demonstrating that a higher consumption of omega-3 may influence its concentration in HM. 2 However, the results on the effects of omega-3 supplementation during gestation are still contradictory. 4 Due to the controversies between the studies, as well as to the importance of the theme for the health of the newborn, this systematic review aims to evaluate the studies that verified the effects of omega-3 supplementation during pregnancy and/or the puerperium on the composition of HM. The bibliographical survey of this theme aims to assist the maternal and infant populations, together with health professionals, to determine the importance of supplementation, offering subsidies for its practice.
Methods
A systematic review of the available literature consisted of a retrospective search of scientific articles that aimed to evaluate the composition of HM after supplementation with omega-3 fatty acids.
The following bibliographic databases have been used: PubMed, Biblioteca Virtual da Saúde (Virtual Health Library [VHL] ) and Web of Science. The search for the articles was performed independently by two researchers, and it began in August and ended in October of 2015. The selected studies were published during the period comprised between 2000 and 2015. The following keywords were used in the search strategy: fatty acids, omega-3, human milk and supplementation.
The bibliographic search was performed according to the established strategy, and resulted in 710 articles. A total of 163 articles were found in the VHL database; however, after reading the abstracts, we have selected 11 thereof; 239 articles were found in the PubMed database; however, we have only selected 21of these; and 308 articles were found in the Web of Science database, from which we have selected 2 articles. Thus, a total of 22 articles have been selected to compose the present study, reiterating that there were 12 articles replicated in the analyzed databases. The others were suppressed for the following reasons: discussion of different associations between omega-3 and HM, such as allergy, visual acuity and growth; literature reviews; studies replicated across different databases; studies published in other languages and/or that were were not available in their entirety. We used a checklist with 27 items and a 4-step flowchart, advocated by PRISMA, 7 which aims to help authors improve the reporting of systematic reviews. Therefore, a summary of each stage of the selection process of articles that composed this systematic review was arranged in the Flowchart (►Fig. 1).
The criteria used in the selection of articles for the review included language (Portuguese, English, Spanish and Italian) and year of publication (2000 to 2015).
The selected articles were compared in relation to the following parameters: year of publication, country of origin, sample size, average age of participants, type of design, rate of follow-up losses, period in which the woman and the milk have been evaluated, omega-3 supplementation period, type of supplement, amount offered, omega-3 evaluation methods, confounding factors controlled in the analysis, estimators used in the statistical analysis, and main results observed.
Results
Once the established strategy was put into practice, 22 articles were selected by bibliographic search to compose the present revision. Four were originated in the United States, one in Canada, one in Denmark, three in Brazil, three in Australia, three in Chile, one in Israel, one in Iceland, one in Mexico, two in Germany, and two in the Netherlands. Regarding the age groups, the majority of the articles (18) only reported the average age of the participants. Regarding language, two articles were written in Spanish, one in Portuguese and the remaining ones in English (►Table 1).
As for the design employed, intervention studies were used in most cases, and there was only one observational study. Information on follow-up losses were obtained from 21 studies. The losses ranged from 0 to 78%. The results among the studies, regarding the period of evaluation of the woman and the milk, were quite dissimilar. Regarding the period of supplementation, it was observed that 12 studies evaluated supplementation in infants, 7 in pregnant women, and only 3 evaluated supplementation both in pregnancy and in the puerperium (►Table 2).
In regards to the type of supplement or food offered to the participants, 3 studies used dairy supplements, 16 provided DHA-rich oils (such as, tuna, single-celled algae, cod, flaxseed), 2 supplied fish (sardine and jure) and 1 study performed food education to increase the consumption of fish sources. As for the method to evaluate the amount of omega 3 in HM, it was observed that all the studies used chromatography. The DHA value ranged from 170 mg to 2,200 mg per day (►Table 3).
Among the 22 selected articles, 9 did not evaluate the consumption of omega-3 food sources. Among those who reported it, the majority (32%) used the food frequency questionnaire (FFQ). Regarding the estimators, it was observed that nine studies used the average, seven used the correlation index, five the median and only one study used the combination of correlation index with the average. Regarding the exclusion criteria, nine articles did not mention them in the methods (►Table 4).
Regarding supplementation, all studies found a positive relationship between the consumption of omega-3 sources and their concentration in HM, therefore, highlighting the importance of supplementation of these fatty acids during pregnancy and/or puerperium, which translates into positive results in both cognitive development and visual acuity.
Discussion
The omega-3 and omega-6 polyunsaturated fatty acids consumed through dietary triglycerides are digested in the small intestines and can then be absorbed, transported into the bloodstream and taken up between tissues throughout the body (including brain, retina and heart). 8 Essential dietary In the 4th week after delivery fatty acids in the form of linoleic acids (LAs) and α À linolenic acids (ALAs) are activated in the forms known as ketoacyl-CoA, and then used for the conversion of long chain polyunsaturated fatty acids and other polyunsaturated products, such as those derived from the series of desaturation and elongation reactions that are particularly active in the liver and, to a lesser extent, in other tissues. 8 Linoleic and ALA fatty acids need to be ingested through food, since the human body does not have enzymes to synthesize them. Some vegetables synthesize them and are, therefore, an abundant source of these fatty acids, as well as the products derived from these vegetables. Omega-3 fatty acids (DHA and EPA) can be synthesized by the human body to a certain level, albeit a very limited one. The consumption of omega-3 sources through diet can be done by ingesting fish or fish oils, and foods enriched or fortified with these important fatty acids. 9 Although ALA in humans is converted to EPA and DHA, the exact percentage of this conversion is unknown, but it is estimated to be low (5% EPA and 0.5% DHA). 10, 11 Due to their enzymatic immaturity, children and especially neonates cannot convert all the DHA required for their development from ALA. 12 Therefore, feeding in the gestational period is of great importance as it determines the type of fatty acid that will accumulate in the fetal tissue. The essential fatty acids are transferred through the placenta, and in the third gestational trimester are deposited in the brain and retina of the fetus. It should be noted that the fetus withdraws a total of 50 to 75mg of polyunsaturated fatty acids from the mother, most of them being DHA. [13] [14] [15] [16] Numerous studies have been conducted to evaluate the effects of the supplementation of omega-3 and its metabolites in pregnancy and puerperium on the composition of HM. This is due to the synthesis of DHA probably occurring minimally in the mammary gland 6, 17, 18 as well as due to the role that this polyunsaturated fatty acid plays on visual acuity, cognition and in the formation of the nervous tissue of the newborn. 19 Although supplementation appears to be the most reliable medium for increasing omega-3 levels in HM, there are numerous differences among the studies evaluated in relation to the following parameters: sample size, study design, timing of omega-3 supplementation (gestation and/or lactation), type of supplementation (fish oil, in natura fish consumption), and amount and type of omega-3 offered (EPA and/or DHA).
Regarding the diversity of the countries where the studies selected for this systematic review were performed, it is worth noting that the consumption of omega-3 rich foods in Western countries is well below that of other countries. 20 In the United States, the intake of omega-3 and its metabolites (DHA and EPA) was estimated at 1.6 and 0.1-0.2 g/day respectively, and the dietary ratio between omega-6 and omega-3 was % 9.8:1. 21 A study with Canadian pregnant women showed that the average daily intake of omega-3 and DHA was 1.45 and 0.082 g/day respectively. 22 Populations living in coastal countries, such as Japan and Norway, where fish are widely consumed, have a higher dietary intake of omega-3 (>1 g/day), and consequently, high concentrations of DHA in their breast milk. 20, 23, 24 Although there is no official dietary recommendation for EPA and DHA in the US, several expert groups suggest a DHA intake of at least 200 mg/day, which may reach 1,000 mg DHA/day for pregnant and lactating women, and 1.4-2.7 g of omega-3, and suggest the omega-6/omega-3 ratio of % 2-5:1. 21, 25 Corroborating the above recommendations, the consensus published by Koletzko et al 26 states that an average intake of at least 200 mg of DHA per day is advisable; it also states that consumption of up to 1 g of DHA or 2 to 7 g of omega-3 per day is safe. This amount can be achieved by consuming one to two servings of fish per week, including fatty fish such as herring, mackerel and salmon. However, it is known that the consumption of fish can contribute significantly to the exposure to contaminants such as methylmercury, which is particularly toxic to the developing brain and possibly harmful to infant growth. To decrease the amounts of methylmercury in the body, one should reduce the intake of contaminated foods during the pregestational and gestational periods. The fish with the highest levels of methylmercury are predatory fish such as marlin, pike, swordfish and shark. However, after an extensive literature review, the consensus points out that the beneficial effects of regular consumption of fish sources of DHA during pregnancy appear to overcome the potential drawbacks of the increased intake of contaminants.
Regarding the period of supplementation, the selected studies presented different time periods (pregnant and/or nursing) when omega-3 supplementation was performed and measured, which may partially justify the differences in the results we found. On this issue, in their randomized clinical trial, Boris et al 27 evaluated two hypotheses, namely: 1) whether omega-3 supplementation during pregnancy increased omega-3 levels at the beginning of breastfeeding; and 2) whether the continuation of supplementation after delivery was necessary to sustain the long-term increase in omega-3 levels. There was a marked drop in omega-3 levels in the group that stopped supplementation during the puerperium. Such a decrease in the concentration of DHA in breast milk as lactation progresses is corroborated by numerous studies. 4, 28, 29 On the other hand, the group that received fish oil during gestation and lactation showed levels of omega-3 three times higher, and double the levels of DHA. 27 It is worth mentioning that polyunsaturated fatty acids are deposited in the brain during the last gestational trimester, and that this process continues after delivery. Furthermore, the neurological development continues during the first years of life. 27 The results found by Ribeiro et al 30 also demonstrated that supplementation with fish oil limited to pregnancy was not as effective as supplementation during pregnancy and lactation. Therefore, supplementation during pregnancy and lactation is recommended by numerous studies. 20, 30, 31 Important issues to take into account in these studies are the type of omega-3 source and the quantity that was supplied. It was observed that most of the selected studies used fish oil to increase the consumption of omega-3; however, some studies have used the supply of fresh food, fortified drinks and food education techniques. The use of fish oil has benefits, but it can lead to low compliance due to its adverse effects, such as fish flavor eructation, digestive discomfort and night sweats. 5, 32 The randomized double blind clinical trial conducted by Dunstan et al 20 aimed to evaluate the effects of fish oil supplementation during pregnancy on the composition of HM and on the development of the infant in the first year of life. The concentration of fatty acids in the milk was analyzed on the third day, sixth week and sixth month after delivery. It was observed that women who received fish oil had a higher concentration of EPA and DHA in the milk on the third day and the sixth week after delivery.
Regarding the consumption of fish, the study by Henderson et al 33 demonstrated that ingesting 100-120 g of sardines 2 to 3 times a week resulted in increased levels of fatty acids without the need for fish oil. Harris et al 34 disagreed 
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The omega-3 content in HM increased significantly over time, from 1.0% of total lipids (TL) at baseline to 6.8% of TL after one week of linseed oil supplementation. The omega-3 content remained high at 2 and 4 weeks. After 4 weeks of supplementation, the omega-3 concentration reached a peak of 7.7% of TL, and then returned to baseline (%1.9% of TL) at 1 week after supplementation Gaete and Atalah 1
Median
Weight, height and BMI GA > 37 weeks and exclusive breastfeeding Women with diabetes, altered lipid metabolism and alcohol and drug dependence After food education, the consumption of fish increased three times in relation to the initial consumption. The increased intake of DHA did not significantly modify the DHA content of the milk. However, in mothers with an intake of DHA with this, and have observed that in order to increase 0.5 to 1 g of DHA in breast milk, it is necessary to consume 350-750 g of 1% fat or 75-150 g of 10% fish fat. In the study by Patin et al, 35 it was observed that the levels of DHA in HM increased with the ingestion of 300 g of sardines per week, with 5% fat, without the need to use fish oil supplementation. This study recommended the consumption of fish two to three times per week during gestation. Gaete and Atalah 1 conducted a prospective study with 26 pregnant women, which consisted of an educational feeding strategy to recommend individual consumption of different preparations based on marine foods. A guide with information on the importance of maternal lactation to the newborn, and on the importance of fish consumption by the mother to increase DHA levels was also distributed. The strategy of food education is considered an important intervention to raise awareness about the need for fish consumption during the gestational and puerperal period.
The study by Atalah et al 5 aimed to evaluate the effects of the introduction of omega-3 fortified milk beverages (DHA and EPA) during gestation on the composition of HM and red blood cells. One-hundred and seventy-five women from the intervention group and 177 from the control group were evaluated in the clinical trial. The pregnant women were evaluated at three moments of the pregnancy and once after delivery to evaluate the consumption near the date of the interview. The evaluation of milk composition was performed in only 16 women, and a 50% increase in omega-3 in breast milk was observed. However, there was no statistical difference between the evaluated groups in relation to the amount of EPA and DHA, probably due to the small sample size.
Regarding the type of omega-3 offered, seven studies offered DHA and EPA, seven offered DHA only, and three offered DHA, arachidonic acid (ARA) and EPA. It was observed that the amount of DHA was always higher than that of EPA, probably because of its important role on the nervous system, cognition and vision. It is worth noting that there is no consensus regarding the optimal levels of DHA consumption at different stages of life. However, most technical groups recommend around 200 to 500 mg/day in the adult population, and, during gestation, it is recommended to consume fish between two to three times per week. 5 There are numerous factors that contribute to the variability of EPA and DHA content in breast milk, such as lactation stage, gestational age, and maternal nutritional status. What is verified is that certain selected studies 20, 27, 30, 36 did not control the analyses for important confounding factors, such as food consumption. Therefore, estimates of association may be compromised by the fact that certain studies did not quantify follow-up losses, but also because they did not control important confounding factors.
All selected articles showed the importance of supplementation of omega-3 in different forms (capsules, dairy drinks, strategy for feeding education, consumption of fish) on the nutritional composition of HM in the gestational and/ or puerperal periods. However, four studies 1,5,27,37 did not reach statistical significance. This can be partially explained by the sample size, which can reduce the strength of the study to elucidate possible associations, possible adhesion reduction in relation to the intake of supplements and the food education practices employed, as well as the follow-up losses, which may cause a decrease in the validity of the results.
Conclusion
Although the studies were disparate in several methodological aspects, the importance of omega-3 supplementation in pregnancy and/or the puerperium, especially DHA, as well as the safety of its supplementation were observed with the data from the studies that composed this systematic review. However, it is of great importance that further studies be conducted to establish the adequate amount of omega-3s and their metabolites during gestation and lactation that will bring benefit to newborns.
